Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM

Qian, Y., Hauber, A., Gonzalez, J., Posner, J., Mohamed, A., Tombal, B., Body, JJ., Gatta, F., & Arellano, J. (2014). Preferences for treatment to delay bone metastases (BM) in patients with castration-resistant prostate cancer (CRPC) at high risk of developing BM. Journal of Clinical Oncology, 32(4, Suppl.), Abstract 117.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article

Community overdose surveillance
Article

Epigenetic biomarkers for smoking cessation
Article

A pilot PT scheme for external assessment of laboratory performance in testing synthetic opioid compounds in urine, plasma, and whole blood